Loading…

Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats

Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology (Philadelphia) 2005-12, Vol.146 (12), p.5247-5256
Main Authors: van Dijk, Gertjan, de Vries, Koert, Nyakas, Csaba, Buwalda, Bauke, Adage, Tiziana, Kuipers, Folkert, Kas, Martien J. H, Adan, Roger A. H, Wilkinson, Charles W, Thiele, Todd E, Scheurink, Anton J. W
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23
cites cdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23
container_end_page 5256
container_issue 12
container_start_page 5247
container_title Endocrinology (Philadelphia)
container_volume 146
creator van Dijk, Gertjan
de Vries, Koert
Nyakas, Csaba
Buwalda, Bauke
Adage, Tiziana
Kuipers, Folkert
Kas, Martien J. H
Adan, Roger A. H
Wilkinson, Charles W
Thiele, Todd E
Scheurink, Anton J. W
description Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.
doi_str_mv 10.1210/en.2005-0472
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1360237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2005-0472</oup_id><sourcerecordid>3130575325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</originalsourceid><addsrcrecordid>eNp1kV-LEzEUxYMobq2--SwBUV86a_5MJtMXoa6rFqoriz6HNHPTzdImNcmI_Qh-azN0sCr6FJL7yz3ncBB6TMk5ZZS8BH_OCBEVqSW7gyZ0XotKUknuogkhlFeSMXmGHqR0W651XfP76Iw2tGkYYxP04xq63kCHFz5E-O424J3Bl9Y6o80BB4tXsM_Oz_DrPuOPIQ9P-QbwB9hqH0yIZYivwRQqRLzYBO9SHqdZ-2q5nOFPETpncsJvHORq6Y-KV2tILh_w8F_n9BDds3qb4NF4TtGXt5efL95Xq6t3y4vFqjKilrliNRVW8w54a4TmLWulNMxqy6mds65t63VJJgmTTWuh7uScWTJfG2ZEI6RlfIpeHffu-_UOOgM-R71V--h2Oh5U0E79OfHuRm3CN0V5QxiXZcHzcUEMX3tIWe1cMrAtiSH0SdE5l20tBqWnf4G3oY--hFOcciKk4EwUanakTAwpRbC_rFCihoYVeDU0rIaGC_7kd_sneKy0AM9GQCejtzZqb1w6cZLJlhePU_TiyIV-_z_JapTkRxJ8F0x0HvYRUjql-afRn3xUy4A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130575325</pqid></control><display><type>article</type><title>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</title><source>Oxford Journals Online</source><creator>van Dijk, Gertjan ; de Vries, Koert ; Nyakas, Csaba ; Buwalda, Bauke ; Adage, Tiziana ; Kuipers, Folkert ; Kas, Martien J. H ; Adan, Roger A. H ; Wilkinson, Charles W ; Thiele, Todd E ; Scheurink, Anton J. W</creator><creatorcontrib>van Dijk, Gertjan ; de Vries, Koert ; Nyakas, Csaba ; Buwalda, Bauke ; Adage, Tiziana ; Kuipers, Folkert ; Kas, Martien J. H ; Adan, Roger A. H ; Wilkinson, Charles W ; Thiele, Todd E ; Scheurink, Anton J. W</creatorcontrib><description>Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2005-0472</identifier><identifier>PMID: 16166222</identifier><identifier>CODEN: ENDOAO</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adipose tissue ; Adrenocorticotropic hormone ; Agonists ; alpha-MSH - administration &amp; dosage ; alpha-MSH - analogs &amp; derivatives ; alpha-MSH - pharmacology ; Animals ; Anorexia - chemically induced ; Binding ; Biological and medical sciences ; c-Fos protein ; Central nervous system ; Correlation ; Corticosterone ; Diet ; Eating - drug effects ; Effectiveness ; Energy balance ; Fundamental and applied biological sciences. Psychology ; Humans ; Hypothalamus ; Immunoreactivity ; Injections, Intraventricular ; Insulin ; Insulin resistance ; Leptin ; Leptin - administration &amp; dosage ; Leptin - pharmacology ; Male ; Medical sciences ; Melanocortin ; Metabolic diseases ; Neural networks ; Neuroendocrine system ; Neurons - drug effects ; Neurosecretory Systems - drug effects ; Obesity ; Obesity - etiology ; Parameters ; Paraventricular Hypothalamic Nucleus - drug effects ; Paraventricular Hypothalamic Nucleus - physiopathology ; Peptides, Cyclic - administration &amp; dosage ; Peptides, Cyclic - pharmacology ; Predictive Value of Tests ; Rats ; Rats, Wistar ; Receptors ; Receptors, Leptin ; Receptors, Melanocortin - agonists ; Vertebrates: endocrinology</subject><ispartof>Endocrinology (Philadelphia), 2005-12, Vol.146 (12), p.5247-5256</ispartof><rights>Copyright © 2005 by The Endocrine Society 2005</rights><rights>2006 INIST-CNRS</rights><rights>Copyright © 2005 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</citedby><cites>FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17278319$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16166222$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Dijk, Gertjan</creatorcontrib><creatorcontrib>de Vries, Koert</creatorcontrib><creatorcontrib>Nyakas, Csaba</creatorcontrib><creatorcontrib>Buwalda, Bauke</creatorcontrib><creatorcontrib>Adage, Tiziana</creatorcontrib><creatorcontrib>Kuipers, Folkert</creatorcontrib><creatorcontrib>Kas, Martien J. H</creatorcontrib><creatorcontrib>Adan, Roger A. H</creatorcontrib><creatorcontrib>Wilkinson, Charles W</creatorcontrib><creatorcontrib>Thiele, Todd E</creatorcontrib><creatorcontrib>Scheurink, Anton J. W</creatorcontrib><title>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.</description><subject>Adipose tissue</subject><subject>Adrenocorticotropic hormone</subject><subject>Agonists</subject><subject>alpha-MSH - administration &amp; dosage</subject><subject>alpha-MSH - analogs &amp; derivatives</subject><subject>alpha-MSH - pharmacology</subject><subject>Animals</subject><subject>Anorexia - chemically induced</subject><subject>Binding</subject><subject>Biological and medical sciences</subject><subject>c-Fos protein</subject><subject>Central nervous system</subject><subject>Correlation</subject><subject>Corticosterone</subject><subject>Diet</subject><subject>Eating - drug effects</subject><subject>Effectiveness</subject><subject>Energy balance</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hypothalamus</subject><subject>Immunoreactivity</subject><subject>Injections, Intraventricular</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Leptin</subject><subject>Leptin - administration &amp; dosage</subject><subject>Leptin - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Melanocortin</subject><subject>Metabolic diseases</subject><subject>Neural networks</subject><subject>Neuroendocrine system</subject><subject>Neurons - drug effects</subject><subject>Neurosecretory Systems - drug effects</subject><subject>Obesity</subject><subject>Obesity - etiology</subject><subject>Parameters</subject><subject>Paraventricular Hypothalamic Nucleus - drug effects</subject><subject>Paraventricular Hypothalamic Nucleus - physiopathology</subject><subject>Peptides, Cyclic - administration &amp; dosage</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Predictive Value of Tests</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors</subject><subject>Receptors, Leptin</subject><subject>Receptors, Melanocortin - agonists</subject><subject>Vertebrates: endocrinology</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp1kV-LEzEUxYMobq2--SwBUV86a_5MJtMXoa6rFqoriz6HNHPTzdImNcmI_Qh-azN0sCr6FJL7yz3ncBB6TMk5ZZS8BH_OCBEVqSW7gyZ0XotKUknuogkhlFeSMXmGHqR0W651XfP76Iw2tGkYYxP04xq63kCHFz5E-O424J3Bl9Y6o80BB4tXsM_Oz_DrPuOPIQ9P-QbwB9hqH0yIZYivwRQqRLzYBO9SHqdZ-2q5nOFPETpncsJvHORq6Y-KV2tILh_w8F_n9BDds3qb4NF4TtGXt5efL95Xq6t3y4vFqjKilrliNRVW8w54a4TmLWulNMxqy6mds65t63VJJgmTTWuh7uScWTJfG2ZEI6RlfIpeHffu-_UOOgM-R71V--h2Oh5U0E79OfHuRm3CN0V5QxiXZcHzcUEMX3tIWe1cMrAtiSH0SdE5l20tBqWnf4G3oY--hFOcciKk4EwUanakTAwpRbC_rFCihoYVeDU0rIaGC_7kd_sneKy0AM9GQCejtzZqb1w6cZLJlhePU_TiyIV-_z_JapTkRxJ8F0x0HvYRUjql-afRn3xUy4A</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>van Dijk, Gertjan</creator><creator>de Vries, Koert</creator><creator>Nyakas, Csaba</creator><creator>Buwalda, Bauke</creator><creator>Adage, Tiziana</creator><creator>Kuipers, Folkert</creator><creator>Kas, Martien J. H</creator><creator>Adan, Roger A. H</creator><creator>Wilkinson, Charles W</creator><creator>Thiele, Todd E</creator><creator>Scheurink, Anton J. W</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20051201</creationdate><title>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</title><author>van Dijk, Gertjan ; de Vries, Koert ; Nyakas, Csaba ; Buwalda, Bauke ; Adage, Tiziana ; Kuipers, Folkert ; Kas, Martien J. H ; Adan, Roger A. H ; Wilkinson, Charles W ; Thiele, Todd E ; Scheurink, Anton J. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adipose tissue</topic><topic>Adrenocorticotropic hormone</topic><topic>Agonists</topic><topic>alpha-MSH - administration &amp; dosage</topic><topic>alpha-MSH - analogs &amp; derivatives</topic><topic>alpha-MSH - pharmacology</topic><topic>Animals</topic><topic>Anorexia - chemically induced</topic><topic>Binding</topic><topic>Biological and medical sciences</topic><topic>c-Fos protein</topic><topic>Central nervous system</topic><topic>Correlation</topic><topic>Corticosterone</topic><topic>Diet</topic><topic>Eating - drug effects</topic><topic>Effectiveness</topic><topic>Energy balance</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hypothalamus</topic><topic>Immunoreactivity</topic><topic>Injections, Intraventricular</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Leptin</topic><topic>Leptin - administration &amp; dosage</topic><topic>Leptin - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Melanocortin</topic><topic>Metabolic diseases</topic><topic>Neural networks</topic><topic>Neuroendocrine system</topic><topic>Neurons - drug effects</topic><topic>Neurosecretory Systems - drug effects</topic><topic>Obesity</topic><topic>Obesity - etiology</topic><topic>Parameters</topic><topic>Paraventricular Hypothalamic Nucleus - drug effects</topic><topic>Paraventricular Hypothalamic Nucleus - physiopathology</topic><topic>Peptides, Cyclic - administration &amp; dosage</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Predictive Value of Tests</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors</topic><topic>Receptors, Leptin</topic><topic>Receptors, Melanocortin - agonists</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Dijk, Gertjan</creatorcontrib><creatorcontrib>de Vries, Koert</creatorcontrib><creatorcontrib>Nyakas, Csaba</creatorcontrib><creatorcontrib>Buwalda, Bauke</creatorcontrib><creatorcontrib>Adage, Tiziana</creatorcontrib><creatorcontrib>Kuipers, Folkert</creatorcontrib><creatorcontrib>Kas, Martien J. H</creatorcontrib><creatorcontrib>Adan, Roger A. H</creatorcontrib><creatorcontrib>Wilkinson, Charles W</creatorcontrib><creatorcontrib>Thiele, Todd E</creatorcontrib><creatorcontrib>Scheurink, Anton J. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Dijk, Gertjan</au><au>de Vries, Koert</au><au>Nyakas, Csaba</au><au>Buwalda, Bauke</au><au>Adage, Tiziana</au><au>Kuipers, Folkert</au><au>Kas, Martien J. H</au><au>Adan, Roger A. H</au><au>Wilkinson, Charles W</au><au>Thiele, Todd E</au><au>Scheurink, Anton J. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2005-12-01</date><risdate>2005</risdate><volume>146</volume><issue>12</issue><spage>5247</spage><epage>5256</epage><pages>5247-5256</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><coden>ENDOAO</coden><abstract>Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>16166222</pmid><doi>10.1210/en.2005-0472</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-7227
ispartof Endocrinology (Philadelphia), 2005-12, Vol.146 (12), p.5247-5256
issn 0013-7227
1945-7170
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1360237
source Oxford Journals Online
subjects Adipose tissue
Adrenocorticotropic hormone
Agonists
alpha-MSH - administration & dosage
alpha-MSH - analogs & derivatives
alpha-MSH - pharmacology
Animals
Anorexia - chemically induced
Binding
Biological and medical sciences
c-Fos protein
Central nervous system
Correlation
Corticosterone
Diet
Eating - drug effects
Effectiveness
Energy balance
Fundamental and applied biological sciences. Psychology
Humans
Hypothalamus
Immunoreactivity
Injections, Intraventricular
Insulin
Insulin resistance
Leptin
Leptin - administration & dosage
Leptin - pharmacology
Male
Medical sciences
Melanocortin
Metabolic diseases
Neural networks
Neuroendocrine system
Neurons - drug effects
Neurosecretory Systems - drug effects
Obesity
Obesity - etiology
Parameters
Paraventricular Hypothalamic Nucleus - drug effects
Paraventricular Hypothalamic Nucleus - physiopathology
Peptides, Cyclic - administration & dosage
Peptides, Cyclic - pharmacology
Predictive Value of Tests
Rats
Rats, Wistar
Receptors
Receptors, Leptin
Receptors, Melanocortin - agonists
Vertebrates: endocrinology
title Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A48%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Anorexigenic%20Efficacy%20of%20Leptin,%20But%20Not%20of%20the%20Melanocortin%20Receptor%20Agonist%20Melanotan-II,%20Predicts%20Diet-Induced%20Obesity%20in%20Rats&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=van%20Dijk,%20Gertjan&rft.date=2005-12-01&rft.volume=146&rft.issue=12&rft.spage=5247&rft.epage=5256&rft.pages=5247-5256&rft.issn=0013-7227&rft.eissn=1945-7170&rft.coden=ENDOAO&rft_id=info:doi/10.1210/en.2005-0472&rft_dat=%3Cproquest_pubme%3E3130575325%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130575325&rft_id=info:pmid/16166222&rft_oup_id=10.1210/en.2005-0472&rfr_iscdi=true